Journal Browser Advanced Search Help
Journal Browser Advanced search HELP
J Korean Endocr Soc. 2007 Jun;22(3):192-202. English. Original Article. https://doi.org/10.3803/jkes.2007.22.3.192
Lee KI , Kim JM , Park JY , Kim JW , Mok JY , Park MK , Lee HJ , Hong SH , Li W , Kim DK .
Department of Internal Medicine, College of Medicine,Dong-A University, Korea.
Department of Pharmacology, College of Medicine,Dong-A University, Korea.
Department of Pathology, College of Medicine,Dong-A University, Korea.
Medical Sciences Research Institutes, College of Medicine,Dong-A University, Korea.
Department of Internal Medicine, Baptist Hospital, Korea.
Department of Internal Medicine, Suyeong Hanseo Hospital, Korea.
Center for Human Nutrition, University of Texas Southwestern Medical Center, USA.
Abstract

BACKGROUND: The aim of this study is to verify the effects of fenofibrate monotherapy and fenofibrate combined with exercise for improving metabolic syndrome and hepatic steatosis. METHODS: Thirty-four weeks old OLETF rats (Otsuka Long-Evans Tokushima Fatty Rats, n = 20) were divided four groups: the regular diet group (n = 5, DD group), the exercise group (n = 5, DE group), the fenofibrate (100 mg/kg) treated group (n = 5, DF group) and the combination treatment group {fenofibrate and exercise (n = 5, EF group)}. After 5 weeks of treatment, blood was drawn for measuring the blood glucose, insulin, lipid and leptin levels. All the subjects were sacrificed for assessment of their body adiposity and hepatic steatosis. RESULTS: The total amount of food intake, body weight and total body weight of the rat were significantly decreased in the EF and DF groups compared to the DD group. The plasma triglyceride and glucose levels were significantly decreased in the EF and DF groups compared to the DD group. The HOMA-IR of EF, DF and DE groups were significantly decreased compared with that of the DD group. The plasma leptin levels of the EF and DF groups were significantly decreased compared with those of the DD and DE groups. The hepatic steatosis index was significantly decreased in the EF and DF groups compared to the DD and DE groups. CONCLUSION: Fenofibrate monotherapy was effective to control three major components (obesity, hypertriglyceridemia and hyperglycemia) of metabolic syndrome and hepatic steatosis in OLETF rats. Exercise combined with fenofibrate treatment showed an additional effect compared to that of fenofibrate monotherapy.

Copyright © 2019. Korean Association of Medical Journal Editors.